Ozenoxacin is a non-fluorinated quinolone antibiotic indicated for the topical treatment of impetigo, noted for its efficacy against bacterial strains that have developed resistance to conventional fluoroquinolones.… Read more



























Ozenoxacin is a non-fluorinated quinolone antibiotic indicated for the topical treatment of impetigo, noted for its efficacy against bacterial strains that have developed resistance to conventional fluoroquinolones. Laboratories require a diverse range of materials to ensure the rigorous quality control and safety of this drug substance during its lifecycle. This collection includes Ozenoxacin reference standards, encompassing both pharmacopeial and non-pharmacopeial impurities, as well as structural analogues and stable isotope labelled compounds. These materials are essential for accurate impurity profiling, method development, and validation protocols. By utilizing these specific standards—such as various benzamido impurities, ester forms, and N-nitroso derivatives—analysts can effectively identify, quantify, and monitor potential degradation products or synthesis by-products, ensuring compliance with regulatory standards throughout the drug development and manufacturing processes.